The roles of FGFR3 and c-MYC in urothelial bladder cancer
Abstract Bladder cancer is one of the most frequently occurring cancers worldwide. At diagnosis, 75% of urothelial bladder cancer cases have non-muscle invasive bladder cancer while 25% have muscle invasive or metastatic disease. Aberrantly activated fibroblast growth factor receptor (FGFR)-3 has be...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01173-z |